查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151571

美國周邊血管液體液體栓塞物質市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2026-2036 年）

U.S. Peripheral Liquid Embolic Agents Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2036
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國周邊血管用液體栓塞物質市場概況

預計到 2025 年，美國周邊血管液體栓塞物質市場價值將達到 9,970 萬美元，到 2026 年將成長至 1.103 億美元，到 2036 年將達到 2.227 億美元，2026 年至 2036 年的年複合成長率（CAGR）為 7.3%。

美國周邊動脈疾病(PAD) 和其他血管疾病的盛行率不斷上升，導致對血管介入治療的需求增加。

此外，微創血管內治療因其許多優勢而日益普及，例如減輕手術帶來的身體負擔、縮短住院時間以及加快康復速度。介入放射學服務的普及和先進導管技術的進步也進一步推動了液體栓塞劑在周邊血管治療中的應用。隨著美國癌症負擔的加重，需要接受周邊血管栓塞術治療血管豐富的腫瘤的患者數量也在增加，尤其是在介入性腫瘤學領域。經動脈栓塞術（TAE）和經動脈化療栓塞術（TACE）等手術能夠選擇性地阻塞為腫瘤供血的血管，因此，能夠實現可控靶血管阻塞的栓塞技術的需求日益成長。

液體栓塞劑尤其有用，因為它們可以滲透到遠端區域和複雜的血管網路，並在目標血管內形成閉塞栓塞物。隨著影像導引栓塞術在肝臟和其他血管豐富的腫瘤治療中的應用日益廣泛，以及微導管輸送和栓塞技術的進步，周邊血管液體栓塞物質的應用範圍正在不斷擴大。在美國，栓塞療法在介入性腫瘤治療市場中佔據相當大的佔有率，預計到2025年，肝癌將成為最大的癌症細分市場。根據美國癌症協會預測，2025年美國將新增42,240例原發性肝癌和肝內膽管癌病例，約30,090例死亡，這凸顯了大量患者需要有效的治療，包括經動脈栓塞術。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國周邊血管液體栓塞物質市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國周邊血管液體栓塞物質市場分析工具

第4章：美國周邊血管液體栓塞物質市場：產品具體估計與趨勢分析

  • 美國周邊血管液體栓塞物質市場：產品特定趨勢分析，2025 年和 2036 年
  • 美國周邊血管液體栓塞物質市場：產品規模與趨勢分析，2021-2036年
  • 乙烯-乙烯醇共聚物（EVOH）
  • 其他栓塞者

第5章：美國周邊血管液體栓塞物質市場：按應用分類的估計和趨勢分析

  • 美國周邊血管液體栓塞物質市場：基於應用的趨勢分析，2025 年和 2036 年
  • 美國周邊血管液體栓塞物質市場：按應用領域分類的規模和趨勢分析，2021-2036年
  • 周圍血管出血
  • 高血管腫瘤
  • 周邊血管畸形/動靜脈畸形
  • 動脈瘤/假性動脈瘤
  • II 型末端洩漏
  • 門靜脈栓塞術（PVE）
  • 靜脈系統應用（精索靜脈曲張、PCS、靜脈曲張）
  • 其他周邊血管栓塞應用

第6章：美國周邊血管液體栓塞物質市場：依最終用途分類的估計與趨勢分析

  • 美國周邊血管液體栓塞物質市場：按最終用途分類的波動分析（2025 年和 2036 年）
  • 美國周邊血管液體栓塞物質市場：按最終用途分類的規模和趨勢分析，2021-2036 年
  • 醫院及介入放射科
  • 門診手術中心（ASC）
  • 專科診所/血管中心
  • 其他

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業市場占有率分析，2025 年
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 新技術的引入
    • 研究與開發
    • 公司簡介
    • Boston Scientific Corporation
    • Terumo Medical Corporation (MicroVention)
    • BlackSwan Vascular (Sirtex Medical)
    • Instylla, Inc.
Product Code: GVR-4-68041-029-9

U.S. Peripheral Liquid Embolic Agents Market Summary

The U.S. peripheral liquid embolic agents market size was valued at USD 99.7 million in 2025 and is projected to grow from USD 110.3 million in 2026 to USD 222.7 million by 2036, at a CAGR of 7.3% from 2026 to 2036. The rising prevalence of peripheral artery disease (PAD) and other vascular disorders in the U.S. is increasing demand for vascular interventions.

In addition, minimally invasive endovascular procedures are gaining adoption due to reduced surgical trauma, shorter hospital stays, and faster recovery. The growing availability of interventional radiology services and advanced catheter-based techniques is further supporting the use of liquid embolic agents in peripheral vascular procedures. The growing cancer burden in the U.S. is increasing the number of patients requiring peripheral vascular embolization for the management of hypervascular tumors, particularly in interventional oncology. Procedures such as transarterial embolization (TAE) and transarterial chemoembolization (TACE) selectively occlude tumor-feeding vessels, creating a demand for embolic technologies capable of controlled, targeted vessel occlusion.

Liquid embolic agents are particularly relevant because they can penetrate distal and complex vascular networks and form an occlusive cast within the targeted vessels. The increasing use of image-guided embolization for liver and other hypervascular tumors, together with advances in microcatheter delivery and embolic technology, is expanding the range of applications for peripheral liquid embolics. In the U.S., embolization therapies accounted for a substantial share of the interventional oncology procedures market, with liver cancer the largest cancer-type segment in 2025. According to the American Cancer Society, 42,240 new cases of primary liver and intrahepatic bile duct cancer were expected in the U.S. in 2025, with approximately 30,090 deaths, highlighting the substantial patient population requiring effective treatment options, including transarterial embolization.

U.S. Peripheral Liquid Embolic Agents Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2036. For this study, Grand View Research has segmented the U.S. peripheral liquid embolic agents market report based on product, application, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2036)
    • Ethylene Vinyl Alcohol Copolymer (EVOH)
    • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2036)
    • Peripheral Vascular Hemorrhage
    • Hypervascular Tumors
    • Peripheral Vascular Malformations / AVMs
    • Aneurysms / Pseudoaneurysms
    • Type II Endoleaks
    • Portal Vein Embolization (PVE)
    • Venous Applications (varicocele, PCS, varicose veins)
    • Other Peripheral Embolization Applications
  • End-use Outlook (Revenue, USD Million, 2021 - 2036)
    • Hospitals & Interventional Radiology (IR) Suites
    • Ambulatory Surgical Centers (ASCs)
    • Specialty Clinics / Vascular Centers
    • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Liquid Embolic Agents Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of peripheral artery disease and other vascular disorders in the U.S.
      • 3.2.1.2. Increasing adoption of minimally invasive endovascular embolization procedures
      • 3.2.1.3. Increasing cancer burden in the country driving interventional oncology
      • 3.2.1.4. Continuous innovation in liquid embolic technologies
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of liquid embolic agents and associated procedure costs
      • 3.2.2.2. Limited reimbursement for selected peripheral embolization procedures
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of peripheral embolization applications beyond oncology
      • 3.2.3.2. Increasing adoption of embolization in trauma and emergency hemorrhage management
      • 3.2.3.3. Growth in outpatient embolization across ambulatory surgical centers
      • 3.2.3.4. Development of AI-guided and image-guided embolization technologies
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Risk of non-target embolization and procedure-related complications
      • 3.2.4.2. Shortage of skilled interventional radiologists and endovascular specialists
  • 3.3. U.S. Peripheral Liquid Embolic Agents Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. U.S. Peripheral Liquid Embolic Agents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Peripheral Liquid Embolic Agents Market: Product Movement Analysis, 2025 & 2036 (USD Million)
  • 4.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Product, 2021 to 2036 (USD Million)
  • 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
    • 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 4.5. Other Embolic Agents
    • 4.5.1. Other Embolic Agents market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 5. U.S. Peripheral Liquid Embolic Agents Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Peripheral Liquid Embolic Agents Market: Application Movement Analysis, 2025 & 2036 (USD Million)
  • 5.3. U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Application 2021 to 2036 (USD Million)
  • 5.4. Peripheral Vascular Hemorrhage
    • 5.4.1. Peripheral Vascular Hemorrhage market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.5. Hypervascular Tumors
    • 5.5.1. Hypervascular Tumors market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.6. Peripheral Vascular Malformations / AVMs
    • 5.6.1. Peripheral Vascular Malformations/AVMs market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.7. Aneurysms / Pseudoaneurysms
    • 5.7.1. Aneurysms / Pseudoaneurysms market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.8. Type II Endoleaks
    • 5.8.1. Type II Endoleaks market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.9. Portal Vein Embolization (PVE)
    • 5.9.1. Portal Vein Embolization (PVE)market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.10. Venous Applications (varicocele, PCS, varicose veins)
    • 5.10.1. Venous Applications (varicocele, PCS, varicose veins) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 5.11. Other Peripheral Embolization Applications
    • 5.11.1. Other Peripheral Embolization Applications market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 6. U.S. Peripheral Liquid Embolic Agents Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global U.S. Peripheral Liquid Embolic Agents Market: End Use Movement Analysis, 2025 & 2036 (USD Million)
  • 6.3. Global U.S. Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by End Use, 2021 to 2036 (USD Million)
  • 6.4. Hospitals & Interventional Radiology (IR) Suites
    • 6.4.1. Hospitals & Interventional Radiology (IR) Suites market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 6.5. Ambulatory Surgical Centers (ASCs)
    • 6.5.1. Ambulatory Surgical Centers (ASCs) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 6.6. Specialty Clinics / Vascular Centers
    • 6.6.1. Specialty Clinics / Vascular Centers market revenue estimates and forecasts, 2021 - 2036 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market revenue estimates and forecasts, 2021 - 2036 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Technology Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. Boston Scientific Corporation
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Terumo Medical Corporation (MicroVention)
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. BlackSwan Vascular (Sirtex Medical)
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Instylla, Inc.
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. peripheral liquid embolic agents market, by product, 2021 - 2036 (USD Million)
  • Table 3 U.S. peripheral liquid embolic agents market, by application, 2021 - 2036 (USD Million)
  • Table 4 U.S. peripheral liquid embolic agents market, by end use, 2021 - 2036 (USD Million)

List of Figures

  • Fig. 1 U.S. peripheral liquid embolic agents market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 U.S. peripheral liquid embolic agents market size and growth prospects (USD Million)
  • Fig. 11 U.S. peripheral liquid embolic agents market: Industry Value Chain Analysis
  • Fig. 12 U.S. peripheral liquid embolic agents market: Market Dynamics
  • Fig. 13 U.S. peripheral liquid embolic agents market: PORTER's Analysis
  • Fig. 14 U.S. peripheral liquid embolic agents market: PESTEL Analysis
  • Fig. 15 U.S. peripheral liquid embolic agents market share by product, 2025 & 2036 (USD Million)
  • Fig. 16 U.S. peripheral liquid embolic agents market, by product: market share, 2025 & 2036
  • Fig. 17 Ethylene Vinyl Alcohol Copolymer (EVOH) market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 18 Other liquid embolics market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 19 U.S. peripheral liquid embolic agents market share by application, 2025 & 2036 (USD Million)
  • Fig. 20 U.S. peripheral liquid embolic agents market, by application: market share, 2025 & 2036
  • Fig. 21 Peripheral vascular hemorrhage market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 22 Hypervascular tumors market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 23 Peripheral vascular malformations / AVMs market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 24 Aneurysms / pseudoaneurysms market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 25 Type II endoleaks market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 26 Portal Vein Embolization (PVE) market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 27 Venous applications (varicocele, PCS, varicose veins) market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 28 Other peripheral embolization applications market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 29 U.S. peripheral liquid embolic agents market share by end use, 2025 & 2036 (USD Million)
  • Fig. 30 U.S. peripheral liquid embolic agents market, by end use: market share, 2025 & 2036
  • Fig. 31 Hospitals & Interventional Radiology (IR) suites market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 32 Ambulatory Surgical Centers (ASCs) market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 33 Specialty clinics / vascular centers market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 34 Others market estimates & forecasts, 2021 - 2036 (USD Million)
  • Fig. 35 Key company categorization
  • Fig. 36 Company market positioning
  • Fig. 37 Key company market share analysis, 2025
  • Fig. 38 Strategic framework